Agraza Seeds And Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.01 Cr
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 M
- Revenue Growth 20.64%
- Profit Growth 45.07%
- Ebitda 39.54%
- Net Worth 111.40%
- Total Assets 5.62%
About Agraza Seeds And Biotech
Agraza Seeds And Biotech Private Limited (ASABPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 April 2017 (Seven years and ten months 9 days old ). Its registered office is in Bargarh, Odisha, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.01 Cr.
The company currently has active open charges totaling ₹7.50 M.
Satish Mutyala, Umamaheswar Godavarthy, Safi Deshmukh, and One other member serve as directors at the Company.
Company Details
-
Location
Bargarh, Odisha, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U01110OR2017PTC026834
-
Company No.
026834
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Apr 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Agraza Seeds And Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Mutyala
|
Director | 05-Apr-2017 | Current |
|
Umamaheswar Godavarthy
|
Director | 05-Apr-2017 | Current |
|
Safi Deshmukh
|
Director | 28-Jun-2022 | Current |
|
Mohammed Shaikh
|
Director | 28-Jun-2022 | Current |
Financial Performance of Agraza Seeds And Biotech.
Agraza Seeds And Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.64% increase. The company also saw a substantial improvement in profitability, with a 45.07% increase in profit. The company's net worth Soared by an impressive increase of 111.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agraza Seeds And Biotech?
In 2023, Agraza Seeds And Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.75 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Feb 2020 | Others | ₹7.50 M | Open |
How Many Employees Work at Agraza Seeds And Biotech?
Unlock and access historical data on people associated with Agraza Seeds And Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agraza Seeds And Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agraza Seeds And Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.